{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:47:02Z","timestamp":1793191622539,"version":"4.5.0"},"reference-count":185,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.yebeh.2022.108661","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T18:40:04Z","timestamp":1647974404000},"page":"108661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["The clinical, economic, and humanistic burden of Dravet syndrome \u2013 A systematic literature review"],"prefix":"10.1016","volume":"130","author":[{"given":"Joseph","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Deighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Candida","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelagh M.","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benit","family":"Maru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline S.","family":"Gofshteyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma S.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer M.","family":"Zuberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2022.108661_b0005","unstructured":"National Organization for rare disorders. Dravet syndrome. 2018."},{"key":"10.1016\/j.yebeh.2022.108661_b0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/dmcn.13591","article-title":"Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey","volume":"60","author":"Lagae","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0015","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/brain\/awz195","article-title":"Incidence and phenotypes of childhood-onset genetic epilepsies: A prospective population-based national cohort","volume":"142","author":"Symonds","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2022.108661_b0020","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy","volume":"68","author":"Claes","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.yebeh.2022.108661_b0025","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.1542\/peds.2015-1807","article-title":"Incidence of dravet syndrome in a US population","volume":"136","author":"Wu","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2022.108661_b0030","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/epi.16386","article-title":"SCN1A-related phenotypes: Epilepsy and beyond","volume":"60","author":"Scheffer","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0035","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/epi.12652","article-title":"Dravet syndrome - From epileptic encephalopathy to channelopathy","volume":"55","author":"Brunklaus","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0040","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/epi.17015","article-title":"Defining Dravet syndrome: An essential pre-requisite for precision medicine trials","volume":"62","author":"Li","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0045","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/aws151","article-title":"Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome","volume":"135","author":"Brunklaus","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2022.108661_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eplepsyres.2016.10.006","article-title":"Mortality in Dravet syndrome","volume":"128","author":"Cooper","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108661_b0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1528-1167.2011.03012.x","article-title":"Dravet syndrome and parent associations: The IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief","volume":"52","author":"Skluzacek","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.seizure.2016.10.014","article-title":"From genotype to phenotype in Dravet disease","volume":"44","author":"Gataullina","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108661_b0065","doi-asserted-by":"crossref","unstructured":"Jansson JS, Hallbook T, Reilly C. Intellectual functioning and behavior in Dravet syndrome: A systematic review. Epilepsy Behav 2020;108 (no pagination).","DOI":"10.1016\/j.yebeh.2020.107079"},{"key":"10.1016\/j.yebeh.2022.108661_b0070","doi-asserted-by":"crossref","unstructured":"Shmuely S, Sisodiya SM, Gunning WB, Sander JW, Thijs RD. Mortality in Dravet syndrome: A review. Epilepsy Behav 2016;Part A. 64: 69-74.","DOI":"10.1016\/j.yebeh.2016.09.007"},{"key":"10.1016\/j.yebeh.2022.108661_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.seizure.2021.02.025","article-title":"A systematic review of adults with Dravet syndrome","author":"Selvarajah","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108661_b0080","doi-asserted-by":"crossref","unstructured":"Rampazzo ACM, Dos Santos RRP, Maluf FA, Simm RF, Marson FAL, Ortega MM, et al. Dravet syndrome and Dravet syndrome-like phenotype: a systematic review of the SCN1A and PCDH19 variants. Neurogenetics 2021: 1-11.","DOI":"10.1007\/s10048-021-00644-7"},{"key":"10.1016\/j.yebeh.2022.108661_b0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.yebeh.2015.10.027","article-title":"Disorders of early language development in Dravet syndrome","volume":"54","author":"Chieffo","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108661_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-176","article-title":"Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy","volume":"8","author":"Nabbout","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.yebeh.2022.108661_b0095","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1528-1167.2010.02925.x","article-title":"Cognitive development in Dravet syndrome: A retrospective, multicenter study of 26 patients","volume":"52","author":"Ragona","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0100","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40263-019-00666-8","article-title":"Recent advances in the drug treatment of Dravet syndrome","volume":"33","author":"Wirrell","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2022.108661_b0105","doi-asserted-by":"crossref","unstructured":"Sullivan J, Cross H. Raising the bar: Fenfluramine sets new treatment standards for Dravet syndrome. Epilepsy Behav 2021;121: 108061-108061.","DOI":"10.1016\/j.yebeh.2021.108061"},{"key":"10.1016\/j.yebeh.2022.108661_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108024","article-title":"Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children\/young adults with Dravet syndrome","volume":"121","author":"Bishop","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jval.2018.03.002","article-title":"The problem of rarity: estimation of prevalence in rare disease","volume":"21","author":"Auvin","year":"2018","journal-title":"Value in Health"},{"key":"10.1016\/j.yebeh.2022.108661_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-4-66","article-title":"Psychometric properties of the Centers for Disease Control and Prevention Health-Related Quality of Life (CDC HRQOL) items in adults with arthritis","volume":"4","author":"Mielenz","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.yebeh.2022.108661_b0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yebeh.2018.11.029","article-title":"Behavior problems and health-related quality of life in Dravet syndrome","volume":"90","author":"Sinoo","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0130","doi-asserted-by":"crossref","unstructured":"Nabbout R, Dirani M, Teng T, Bianic F, Martin M, Holland R, et al. Impact of childhood Dravet syndrome on care givers of patients with DS, a major impact on mothers. Epilepsy Behav 2020;108 (no pagination).","DOI":"10.1016\/j.yebeh.2020.107094"},{"key":"10.1016\/j.yebeh.2022.108661_b0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2018.12.018","article-title":"Caregiver impact and health service use in high and low severity Dravet syndrome: A multinational cohort study","volume":"65","author":"Lagae","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108661_b0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yebeh.2017.12.034","article-title":"The direct and indirect costs of Dravet syndrome","volume":"80","author":"Whittington","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.yebeh.2018.01.003","article-title":"Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey","volume":"80","author":"Campbell","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0150","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejpn.2019.02.014","article-title":"Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany","volume":"23","author":"Strzelczyk","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108198","article-title":"Parent caregivers of children with Dravet syndrome: Perspectives, needs, and opportunities for clinical research","volume":"122","author":"Juand\u00f3-Prats","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.yebeh.2022.108661_b0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2022.108661_b0170","unstructured":"National Institute for Health and Care Excellence. Appendix A: Literature search strategies."},{"key":"10.1016\/j.yebeh.2022.108661_b0175","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE reporting guidelines for observational studies","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.yebeh.2022.108661_b0180","series-title":"Poster presented at: European Paediatric Neurology Society Athens, Greece","article-title":"OC041 - Death in SCN1A positive Dravet Syndrome \u2013 Findings from a 10-year follow-up of 141 cases","author":"Brunklaus","year":"2019"},{"key":"10.1016\/j.yebeh.2022.108661_b0185","unstructured":"Golbeck E. Nocturnal seizures and sleep variability in children and young adults with dravet syndrome. In: Poster presented at: American Epilepsy Society. New Orleans, USA; 2018."},{"issue":"Supplement 2","key":"10.1016\/j.yebeh.2022.108661_b0190","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1016\/j.jval.2019.04.1307","article-title":"Pnd34 economic burden of probable Lennox-Gastaut syndrome, probable Dravet syndrome, and other refractory epilepsies for United States medicaid health plans","volume":"22","author":"Hollenack","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.yebeh.2022.108661_b0195","unstructured":"Li W, Schneider AL, Scheffer IE. 116 - Delineating the phenotypic limits of Dravet syndrome due to SCN1A pathogenic variants. In: Presented at: Dravet Syndrome Foundation Roundtable. Baltimore, USA; 2019."},{"key":"10.1016\/j.yebeh.2022.108661_b0200","series-title":"Poster presented at: American Epilepsy Society. New Orleans, USA","article-title":"The clinical course of dravet syndrome from childhood to adulthood. A long-term follow-up study with 51 patients","author":"Mayer","year":"2018"},{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2022.108661_b0205","first-page":"62","article-title":"The clinical and socioeconomic impact of Dravet syndrome in the UK","volume":"61","author":"Pagano","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0210","doi-asserted-by":"crossref","unstructured":"Patel A, Reaven NL, Funk SE, Story TJ, Chez M. The direct cost burden of illness (BOI) of Dravet syndrome (DS) in the US (P6.290). In: Poster presented at: American Academy of Neurology. Los Angeles, USA; 2018.","DOI":"10.1212\/WNL.90.15_supplement.P6.290"},{"issue":"Suppl 3","key":"10.1016\/j.yebeh.2022.108661_b0215","first-page":"S12","article-title":"Dravet syndrome, PCDH19-related epilepsy and SCN1A-related epilepsies: Early differential diagnosis","volume":"59","author":"Pellegrin","year":"2018","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.yebeh.2022.108661_b0220","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1016\/j.jval.2019.04.1691","article-title":"Pro58 quality of life in patients with Dravet syndrome or Lennox Gastaut syndrome in the UK: higher seizure frequency has a substantial negative impact on quality of life","volume":"22","author":"Radu","year":"2019","journal-title":"Value Health"},{"issue":"10-A SUPPL","key":"10.1016\/j.yebeh.2022.108661_b0225","first-page":"S57","article-title":"Inpatient hospitalizations and readmissions among patients with probable lennox-gastaut syndrome, dravet syndrome, tuberous sclerosis complex, and other refractory epilepsies","volume":"25","author":"Stockl","year":"2019","journal-title":"J Manage Care Special Pharm"},{"key":"10.1016\/j.yebeh.2022.108661_b0230","unstructured":"Sullivan J, Zafar M, Flamini R, Knupp K, Ziobro J, Perry S, et al. 81 - Observational study to investigate cognition and other non-seizure comorbidities in children and adolescents with Dravet syndrome: patient analysis of the BUTTERFLY study. In: Poster presented at: American Epilepsy Society. Virtual Meeting; 2020."},{"key":"10.1016\/j.yebeh.2022.108661_b0235","series-title":"Poster presented at: American Epilepsy Society. Baltimore, USA","article-title":"443 - Parental reports of nocturnal seizures, sleep disturbances and dysautonomias in young people with Dravet syndrome","author":"Van Nuland","year":"2019"},{"issue":"Suppl","key":"10.1016\/j.yebeh.2022.108661_b0240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2019.10.841","article-title":"Epidemiology, healthcare resource use, and mortality in patients with probable dravet syndrome: A population-based study on German health insurance data","volume":"405","author":"Strzelczyk","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2022.108661_b0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yebeh.2015.04.057","article-title":"Autism and behavior in adult patients with Dravet syndrome (DS)","volume":"47","author":"Berkvens","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0250","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1111\/epi.16297","article-title":"Dravet syndrome: Early electroclinical findings and long-term outcome in adolescents and adults","volume":"60","author":"Darra","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0255","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/epi.14191","article-title":"Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes","volume":"59","author":"de Lange","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0260","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1528-1167.2007.01475.x","article-title":"A Screening test for the prediction of Dravet syndrome before one year of age","volume":"49","author":"Hattori","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0265","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/dmcn.12709","article-title":"Dravet syndrome in Sweden: A population-based study","volume":"57","author":"Rosander","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0270","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1528-1167.2011.03001.x","article-title":"Dravet syndrome: The long-term outcome","volume":"52","author":"Genton","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yebeh.2017.05.037","article-title":"Age-related, \u201cSleep\/nocturnal\u201d tonic and tonic clonic seizure clusters are underdiagnosed in patients with Dravet Syndrome","volume":"74","author":"Losito","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0280","series-title":"Poster presented at: American Epilepsy Society. Baltimore, USA","article-title":"116 - Delineating the phenotypic limits of Dravet syndrome due to SCN1A pathogenic variants","author":"Li","year":"2019"},{"key":"10.1016\/j.yebeh.2022.108661_b0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yebeh.2017.06.031","article-title":"Dravet syndrome: Characteristics, comorbidities, and caregiver concerns","volume":"74","author":"Villas","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"Suppl 2","key":"10.1016\/j.yebeh.2022.108661_b0290","first-page":"242","article-title":"Autism spectrum disorders in dravet syndrome: Delineation of a specific phenotype?","volume":"60","author":"Ouss","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0295","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/epi.12532","article-title":"Long-term course of Dravet syndrome: A study from an epilepsy center in Japan","volume":"55","author":"Takayama","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0300","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/epi.12303","article-title":"Stiripentol in Dravet syndrome: Results of a retrospective U.S. study","volume":"54","author":"Wirrell","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0305","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archneurol.2011.3275","article-title":"Progressive gait deterioration in adolescents with Dravet syndrome","volume":"69","author":"Rodda","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0310","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/dmcn.13601","article-title":"Sleep problems in Dravet syndrome: a modifiable comorbidity","volume":"60","author":"Licheni","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108661_b0315","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-018-9229-x","article-title":"Few individuals with Lennox-Gastaut syndrome have autism spectrum disorder: A comparison with Dravet syndrome","volume":"10","author":"He","year":"2018","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.yebeh.2022.108661_b0320","doi-asserted-by":"crossref","unstructured":"Juanes M, Veneruzzo G, Loos M, Reyes G, Araoz HV, Garcia FM, et al. Molecular diagnosis of epileptic encephalopathy of the first year of life applying a customized gene panel in a group of Argentinean patients. Epilepsy Behav 2020;111.","DOI":"10.1016\/j.yebeh.2020.107322"},{"key":"10.1016\/j.yebeh.2022.108661_b0325","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0883073807300294","article-title":"Dravet syndrome (severe myoclonic epilepsy in infancy): A retrospective study of 16 patients","volume":"22","author":"Korff","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0330","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.0b013e31820c309b","article-title":"Genotype-phenotype associations in SCN1A-related epilepsies","volume":"76","author":"Zuberi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108661_b0335","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/brain\/awr129","article-title":"Dravet syndrome as epileptic encephalopathy: Evidence from long-term course and neuropathology","volume":"134","author":"Catarino","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2022.108661_b0340","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.dib.2018.08.122","article-title":"Data on mutations and Clinical features in SCN1A or SCN2A gene","volume":"22","author":"Kong","year":"2019","journal-title":"Data in Brief"},{"key":"10.1016\/j.yebeh.2022.108661_b0345","doi-asserted-by":"crossref","unstructured":"Jiang T, Shen Y, Chen H, Yuan Z, Mao S, Gao F. Clinical and molecular analysis of epilepsy-related genes in patients with Dravet syndrome. Medicine (United States) 2018;97 (50) (no pagination).","DOI":"10.1097\/MD.0000000000013565"},{"issue":"Suppl 3","key":"10.1016\/j.yebeh.2022.108661_b0350","first-page":"S312","article-title":"Influence of contra-indicated medication use on cognitive outcomes in dravet syndrome and age at first afebrile seizure as clinical predictor in SCN1A-related seizure phenotypes","volume":"59","author":"De Lange","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0355","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/09297049.2014.959480","article-title":"Cognitive characterization of children with Dravet syndrome: A neurodevelopmental perspective","volume":"21","author":"Acha","year":"2015","journal-title":"Child Neuropsychol"},{"key":"10.1016\/j.yebeh.2022.108661_b0360","doi-asserted-by":"crossref","unstructured":"Brown A, Arpone M, Schneider AL, Micallef S, Anderson VA, Scheffer IE. Cognitive, behavioral, and social functioning in children and adults with Dravet syndrome. Epilepsy Behav 2020;112 (no pagination).","DOI":"10.1016\/j.yebeh.2020.107319"},{"key":"10.1016\/j.yebeh.2022.108661_b0365","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.seizure.2018.09.010","article-title":"Dravet syndrome in South African infants: Tools for an early diagnosis","volume":"62","author":"Esterhuizen","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108661_b0370","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/epi.13639","article-title":"Clinical implications of SCN1A missense and truncation variants in a large Japanese cohort with Dravet syndrome","volume":"58","author":"Ishii","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0375","article-title":"Independent walking and cognitive development in preschool children with Dravet syndrome","author":"Verheyen","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0380","doi-asserted-by":"crossref","unstructured":"Berg AT, Gaebler-Spira D, Wilkening G, Zelko F, Knupp K, Dixon-Salazar T, et al. Nonseizure consequences of Dravet syndrome, KCNQ2-DEE, KCNB1-DEE, Lennox-Gastaut syndrome, ESES: A functional framework. Epilepsy Behav 2020;111 (no pagination).","DOI":"10.1016\/j.yebeh.2020.107287"},{"key":"10.1016\/j.yebeh.2022.108661_b0385","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000003635","article-title":"Dysarthria and broader motor speech deficits in Dravet syndrome","volume":"88","author":"Turner","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108661_b0390","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1017\/S0012162206001629","article-title":"Coping with Dravet syndrome: parental experiences with a catastrophic epilepsy","volume":"48","author":"Nolan","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0395","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/dmcn.14147","article-title":"Motor development in children with Dravet syndrome","volume":"61","author":"Verheyen","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0400","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1528-1167.2012.03583.x","article-title":"Dravet syndrome: Seizure control and gait in adults with different SCN1A mutations","volume":"53","author":"Rilstone","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0405","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.yebeh.2018.09.041","article-title":"Outcomes and comorbidities of SCN1A-related seizure disorders","volume":"90","author":"de Lange","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0410","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1528-1167.2011.03002.x","article-title":"Mortality in Dravet syndrome: Search for risk factors in Japanese patients","volume":"52","author":"Sakauchi","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0415","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yebeh.2019.01.045","article-title":"The direct cost of seizure events in severe childhood-onset epilepsies: A retrospective claims-based analysis","volume":"93","author":"Reaven","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0420","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/epi.16099","article-title":"A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany","volume":"60","author":"Strzelczyk","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0425","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1528-1167.2011.03129.x","article-title":"Comorbidities and predictors of health-related quality of life in Dravet syndrome","volume":"52","author":"Brunklaus","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0430","series-title":"Poster presented at: American Epilepsy Society. Baltimore, USA","article-title":"234 - Long-term outcome and mortality in SCN1A positive Dravet syndrome \u2013 findings from a 10-year follow up of 141 cases","author":"Brunklaus","year":"2019"},{"key":"10.1016\/j.yebeh.2022.108661_b0435","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejpn.2018.09.012","article-title":"More daytime sleepiness and worse quality of sleep in patients with Dravet Syndrome compared to other epilepsy patients","volume":"23","author":"Schoonjans","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0440","doi-asserted-by":"crossref","unstructured":"Hahn CD, Jiang Y, Villanueva V, Zolnowska M, Arkilo D, Forgacs PB, et al. Efficacy, safety and tolerability of Soticlestat (TAK-935\/OV935) as adjunctive therapy in pediatric patients with Dravet syndrome and Lennox-Gastaut syndrome (ELEKTRA) (4234). In: AAN Enterprises; 2021.","DOI":"10.1212\/WNL.96.15_supplement.4234"},{"key":"10.1016\/j.yebeh.2022.108661_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106646","article-title":"A phase 1b\/2a study of soticlestat as adjunctive therapy in participants with developmental and\/or epileptic encephalopathies","volume":"174","author":"Halford","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108661_b0450","unstructured":"United States National Library of Medicine. A study of lorcaserin as adjunctive treatment in participants with Dravet syndrome (MOMENTUM 1). 2021."},{"key":"10.1016\/j.yebeh.2022.108661_b0455","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2022.108661_b0460","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2022.108661_b0465","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2022.108661_b0470","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.yebeh.2013.11.021","article-title":"Cognitive and adaptive evaluation of 21 consecutive patients with Dravet syndrome","volume":"31","author":"Villeneuve","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0475","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199806113382402","article-title":"Long-term prognosis of seizures with onset in childhood","volume":"338","author":"Sillanp\u00e4\u00e4","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2022.108661_b0480","unstructured":"Donner EJ. Dravet Syndrome Foundation. 2018."},{"key":"10.1016\/j.yebeh.2022.108661_b0485","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1212\/WNL.0000000000008741","article-title":"Clinical risk factors in SUDEP: a nationwide population-based case-control study","volume":"94","author":"Sveinsson","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108661_b0490","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5698\/1535-7511.17.3.180","article-title":"Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"17","author":"Harden","year":"2017","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2022.108661_b0495","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejpn.2019.12.005","article-title":"The concept of disease modification","volume":"24","author":"Cross","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0500","first-page":"71","article-title":"Severe myoclonic epilepsy in infancy: Dravet syndrome","volume":"95","author":"Dravet","year":"2005","journal-title":"Adv Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0505","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.braindev.2020.10.004","article-title":"Multicenter prospective longitudinal study in 34 patients with Dravet syndrome: Neuropsychological development in the first six years of life","volume":"43","author":"Battaglia","year":"2021","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2022.108661_b0510","unstructured":"United States National Library of Medicine. Natural History Study of Infants and Children with SCN1A-positive Dravet Syndrome (ENVISION). 2021."},{"key":"10.1016\/j.yebeh.2022.108661_b0515","unstructured":"Dravet Syndrome Foundation. The BUTTERFLY Study. 2019."},{"key":"10.1016\/j.yebeh.2022.108661_b0520","unstructured":"Brunklaus A, Cross H. Professional webinar: Gene therapies for Dravet Syndrome & UK Clinical Trials. 2021."},{"key":"10.1016\/j.yebeh.2022.108661_b0525","unstructured":"Brunklaus A, Scheffer IE, Perry S, Wheless J, Sullivan J, Knupp K, Roberts C, Boronat S, Laux L, Smeyers P, Segal E, Holder D, Patel A, Lallas M, Phillips S, Dlugos D, Nickels K, Lal D, Wirrell E, Zuberi S, Christensen S, Gofshteyn J, Huang N, James E, Maru B, O\u2019Donnell R, Vila MC, Rico S. The ENVISION Study: an international, prospective natural history study in young children with SCN1A+ Dravet syndrome. In: American Epilepsy Society; 2021."},{"key":"10.1016\/j.yebeh.2022.108661_b0530","unstructured":"Wirrell E, Knupp K, Chen D, Zafar M, Flamini R, Ventola P, Stutely J, Brathwaite C, Avenda\u00f1o J, Wyant N, Parkerson K, Ticho B, Sullivan J. BUTTERFLY, an observational study to investigate cognition and other non-seizure comorbidities in children and adolescents with Dravet syndrome. American Epilepsy Society; 2021."},{"key":"10.1016\/j.yebeh.2022.108661_b0535","unstructured":"United States Food and Drug Administration. EPIDIOLEX\u00ae (cannabidiol) oral solution, CX. 2018."},{"key":"10.1016\/j.yebeh.2022.108661_b0540","unstructured":"The Wall Street Journal. New marijuana-based epilepsy treatment to cost $32,500 a year. 2018."},{"key":"10.1016\/j.yebeh.2022.108661_b0545","unstructured":"Ray F. Fintepla Approval \u2018Fills us with a lot of pride,\u2019 Zogenix CEO Says in Interview. 2020."},{"key":"10.1016\/j.yebeh.2022.108661_b0550","unstructured":"IBM Mircomedex. IBM Micromedex RED Book. 2021."},{"key":"10.1016\/j.yebeh.2022.108661_b0555","unstructured":"United States Food and Drug Administration. FINTEPLA\u00ae (fenfluramine) oral solution, CIV. 2020."},{"key":"10.1016\/j.yebeh.2022.108661_b0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107459","article-title":"Epidemiology of status epilepticus in the United States: A systematic review","volume":"112","author":"Lu","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0565","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/0883073817698629","article-title":"Increasing ketamine use for refractory status epilepticus in US pediatric hospitals","volume":"32","author":"Keros","year":"2017","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0570","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamapediatrics.2014.210","article-title":"Costs of autism spectrum disorders in the United Kingdom and the United States","volume":"168","author":"Buescher","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.yebeh.2022.108661_b0575","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/gps.5182","article-title":"The clinical and economic burden among caregivers of patients with Alzheimer's disease in Canada","volume":"34","author":"Szabo","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.yebeh.2022.108661_b0580","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02883327","article-title":"Health effects of caregiving: the caregiver health effects study: an ancillary study of the Cardiovascular Health Study","volume":"19","author":"Schulz","year":"1997","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.yebeh.2022.108661_b0585","unstructured":"Mosteller F, Falotico-Taylor J. Quality of life and technology assessment: National Academy Press Washington, DC; 1989."},{"key":"10.1016\/j.yebeh.2022.108661_b0590","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s11136-020-02497-3","article-title":"Parental health spillover effects of paediatric rare genetic conditions","volume":"29","author":"Wu","year":"2020","journal-title":"Qual Life Res"},{"key":"10.1016\/j.yebeh.2022.108661_b0595","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/dmcn.12938","article-title":"Health-related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross-sectional study","volume":"58","author":"Landfeldt","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0600","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11136-019-02355-x","article-title":"Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review","volume":"29","author":"Szabo","year":"2020","journal-title":"Qual Life Res"},{"key":"10.1016\/j.yebeh.2022.108661_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108239","article-title":"The impact of seizure frequency on quality of life in patients with Lennox-Gastaut syndrome or Dravet syndrome","volume":"123","author":"Auvin","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108206","article-title":"Dravet syndrome: Effects on informal caregivers\u2019 mental health and quality of life\u2013A systematic review","volume":"122","author":"Gon\u00e7alves","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108324","article-title":"Impact of developmental and epileptic encephalopathies on caregivers: A literature review","volume":"124","author":"Gallop","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0620","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/acn3.51017","article-title":"Cardiac arrhythmias in Dravet syndrome: an observational multicenter study","volume":"7","author":"Shmuely","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0625","doi-asserted-by":"crossref","unstructured":"Dhamija R, Erickson M, St Louis E, Kotagal S. Sleep abnormalities in children with dravet syndrome. Neurology. Conference: 66th American Academy of Neurology Annual Meeting, AAN 2014;82.","DOI":"10.1212\/WNL.82.10_supplement.P1.345"},{"key":"10.1016\/j.yebeh.2022.108661_b0630","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1528-1167.2009.02466.x","article-title":"A long-term follow-up study of Dravet syndrome up to adulthood","volume":"51","author":"Akiyama","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0635","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5270503","article-title":"Dravet syndrome in Lebanon: First report on cases with SCN1A mutations","volume":"2019","author":"Alame","year":"2019","journal-title":"Case Rep Med"},{"key":"10.1016\/j.yebeh.2022.108661_b0640","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.eplepsyres.2017.01.007","article-title":"Movement-activated cortical myoclonus in Dravet syndrome","volume":"130","author":"Canafoglia","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108661_b0645","doi-asserted-by":"crossref","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30: 389-399.","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"10.1016\/j.yebeh.2022.108661_b0650","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0387-7604(01)00276-5","article-title":"Severe myoclonic epilepsy in infants\u2013a review based on the Tokyo Women's Medical University series of 84 cases","volume":"23","author":"Oguni","year":"2001","journal-title":"Brain Dev"},{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2022.108661_b0655","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1016\/j.eplepsyres.2005.11.026","article-title":"Dravet syndrome: a study of 53 patients","volume":"70","author":"Caraballo","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108661_b0660","article-title":"The direct costs of Dravet's syndrome before and after diagnosis assessment","author":"Ceska","year":"2020","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2022.108661_b0665","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0670","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1469-8749.2011.03968.x","article-title":"Overall management of patients with Dravet syndrome","volume":"53","author":"Ceulemans","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-8749.2011.03964.x","article-title":"Dravet syndrome history","volume":"53","author":"Dravet","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0680","unstructured":"Dravet C BM, Guerrini R, Giraud N, Roger J, Severe myoclonic epilepsy. In: Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, editors. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. London: John Libbey; 1992. p. 75\u201388. . 1992."},{"key":"10.1016\/j.yebeh.2022.108661_b0685","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eplepsyres.2016.05.012","article-title":"Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study","volume":"125","author":"De Liso","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108661_b0690","doi-asserted-by":"crossref","unstructured":"Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009. In: Wiley Online Library; 2010.","DOI":"10.1111\/j.1528-1167.2010.02522.x"},{"key":"10.1016\/j.yebeh.2022.108661_b0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci10110889","article-title":"Fatal status epilepticus in dravet syndrome","volume":"10","author":"De Liso","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.yebeh.2022.108661_b0700","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.yebeh.2011.05.003","article-title":"Perceptions of fever and fever management practices in parents of children with Dravet syndrome","volume":"21","author":"Desnous","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0705","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejpn.2019.09.010","article-title":"Gait abnormalities in people with Dravet syndrome: A cross-sectional multi-center study","volume":"23","author":"Di Marco","year":"2019","journal-title":"Eur J Paediatric Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0710","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3988\/jcn.2017.13.1.62","article-title":"SCN1A gene mutation and adaptive functioning in 18 Vietnamese children with Dravet syndrome","volume":"13","author":"Do","year":"2017","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2019.12.009","article-title":"A single-center, retrospective analysis of genotype-phenotype correlations in children with Dravet syndrome","volume":"75","author":"Gertler","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108661_b0720","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/WNL.0000000000002859","article-title":"Motor neuropathy contributes to crouching in patients with Dravet syndrome","volume":"87","author":"Gitiaux","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108661_b0725","doi-asserted-by":"crossref","unstructured":"Commission. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981;22: 489-501.","DOI":"10.1111\/j.1528-1157.1981.tb06159.x"},{"key":"10.1016\/j.yebeh.2022.108661_b0730","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jpeds.2018.07.055","article-title":"Comorbidities of rare epilepsies: results from the rare epilepsy network","volume":"203","author":"Ho","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2022.108661_b0735","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.braindev.2011.08.009","article-title":"Maturation of EEG oscillations in children with sodium channel mutations","volume":"34","author":"Holmes","year":"2012","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2022.108661_b0740","doi-asserted-by":"crossref","unstructured":"Drummond MF, McGuire A. Economic evaluation in health care: merging theory with practice: OUP Oxford; 2001.","DOI":"10.1093\/oso\/9780192631770.001.0001"},{"key":"10.1016\/j.yebeh.2022.108661_b0745","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/epi.13671","article-title":"Instruction manual for the ILAE 2017 operational classification of seizure types","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0750","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.braindev.2013.10.004","article-title":"Early clinical features and diagnosis of Dravet syndrome in 138 Chinese patients with SCN1A mutations","volume":"36","author":"Xu","year":"2014","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2022.108661_b0755","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.clinph.2014.06.024","article-title":"Ictal ontogeny in Dravet syndrome","volume":"126","author":"Kim","year":"2015","journal-title":"Clin Neurophysiol"},{"issue":"7","key":"10.1016\/j.yebeh.2022.108661_b0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041802","article-title":"Identification of SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome","volume":"7","author":"Kwong","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.yebeh.2022.108661_b0765","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0770","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eplepsyres.2014.02.019","article-title":"When is a child with status epilepticus likely to have Dravet syndrome?","volume":"108","author":"Le Gal","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108661_b0775","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.braindev.2014.10.003","article-title":"Electroencephalographic features of patients with SCN1A-positive dravet syndrome","volume":"37","author":"Lee","year":"2015","journal-title":"Brain Dev"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108661_b0780","article-title":"Novel and de novo mutations in pediatric refractory epilepsy","volume":"11","author":"Liu","year":"2018","journal-title":"Mol Brain"},{"key":"10.1016\/j.yebeh.2022.108661_b0785","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0790","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yebeh.2018.12.016","article-title":"Efficacy of the ketogenic diet in Chinese children with Dravet syndrome: A focus on neuropsychological development","volume":"92","author":"Liu","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0795","doi-asserted-by":"crossref","unstructured":"Mitta N, Menon RN, McTague A, Radhakrishnan A, Sundaram S, Cherian A, Madhavilatha GK, Mannan AU, Nampoothiri S, Thomas SV. Genotype-phenotype correlates of infantile-onset developmental & epileptic encephalopathy syndromes in South India: A single centre experience. Epilepsy Res 2020;166 (no pagination).","DOI":"10.1016\/j.eplepsyres.2020.106398"},{"key":"10.1016\/j.yebeh.2022.108661_b0800","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/epi.14438","article-title":"Heart rate variability in epilepsy: A potential biomarker of sudden unexpected death in epilepsy risk","volume":"59","author":"Myers","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0805","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.yebeh.2017.08.029","article-title":"Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome","volume":"78","author":"Nabbout","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0810","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/dmcn.14186","article-title":"Perception of impact of Dravet syndrome on children and caregivers in multiple countries: looking beyond seizures","volume":"61","author":"Nabbout","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0815","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.braindev.2015.12.014","article-title":"Cognitive-behavioral profiles in teenagers with Dravet syndrome","volume":"38","author":"Olivieri","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2022.108661_b0820","doi-asserted-by":"crossref","unstructured":"Dravet C, Oguni H. Dravet syndrome (severe myoclonic epilepsy in infancy). Handbook of Clinical Neurology 2013;111: 627-633.","DOI":"10.1016\/B978-0-444-52891-9.00065-8"},{"key":"10.1016\/j.yebeh.2022.108661_b0825","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eplepsyres.2011.10.010","article-title":"Early clinical features in Dravet syndrome patients with and without SCN1A mutations","volume":"99","author":"Petrelli","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108661_b0830","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1528-1157.2001.10401.x","article-title":"A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology","volume":"42","author":"Engel","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0835","unstructured":"Dravet C. Les epilepsies graves de l'enfant. 1978."},{"key":"10.1016\/j.yebeh.2022.108661_b0840","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1528-1167.2011.03053.x","article-title":"Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome","volume":"52","author":"Sakauchi","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0845","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/brain\/awg053","article-title":"Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures","volume":"126","author":"Fujiwara","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2022.108661_b0850","first-page":"103","article-title":"Severe myoclonic epilepsy in infancy: clinical analysis and relation to SCN1A mutations in a Japanese cohort","volume":"95","author":"Oguni","year":"2005","journal-title":"Adv Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0855","doi-asserted-by":"crossref","DOI":"10.1111\/epi.16690","article-title":"Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real-world study","author":"Specchio","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0860","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0883073811419262","article-title":"Electroencephalographic features in Dravet syndrome: Five-year follow-up study in 22 patients","volume":"27","author":"Specchio","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0865","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yebeh.2014.03.014","article-title":"Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam","volume":"34","author":"Strzelczyk","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108661_b0870","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0875","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4149\/gpb_2016002","article-title":"Novel SCN1A variants in Dravet syndrome and evaluating a wide approach of patient selection","volume":"35","author":"Surovy","year":"2016","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.yebeh.2022.108661_b0880","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eplepsyres.2016.05.015","article-title":"PCDH19-related epilepsy and Dravet Syndrome: Face-off between two early-onset epilepsies with fever sensitivity","volume":"125","author":"Trivisano","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108661_b0885","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1046\/j.1528-1157.2001.22001.x","article-title":"Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology","volume":"42","author":"Blume","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108661_b0890","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.gaitpost.2018.06.208","article-title":"P 055 - Gait Profile Scores indicate that gait deviations in children and young adults with Dravet Syndrome mainly manifest in transverse plane","volume":"65","author":"Verheyen","year":"2018","journal-title":"Gait Posture"},{"key":"10.1016\/j.yebeh.2022.108661_b0895","first-page":"95","article-title":"\u201cSevere myoclonic epilepsy in infancy\u201d relevance for the clinician of severe epilepsy starting in infancy","volume":"104","author":"Ceulemans","year":"2004","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.yebeh.2022.108661_b0900","doi-asserted-by":"crossref","unstructured":"Wu YW, McDaniel SS, Sullivan J, Meisler MH, Walsh EM, Li S, Kuzniewicz MW, Xu S. Incidence of Dravet syndrome in a U.S. population. Ann Neurol 2015;19: S155.","DOI":"10.1542\/peds.2015-1807"},{"key":"10.1016\/j.yebeh.2022.108661_b0905","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(04)00808-7","article-title":"Fever, genes, and epilepsy","volume":"3","author":"Baulac","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0910","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/jhg.2010.39","article-title":"Analysis of SCN1A mutation and parental origin in patients with Dravet syndrome","volume":"55","author":"Sun","year":"2010","journal-title":"J Hum Genet"},{"key":"10.1016\/j.yebeh.2022.108661_b0915","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0883073818811538","article-title":"Efficacy of stiripentol and the clinical outcome in Dravet syndrome","volume":"34","author":"Yildiz","year":"2019","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108661_b0920","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eplepsyres.2019.02.014","article-title":"Efficacy and tolerability of perampanel in pediatric patients with Dravet syndrome","volume":"154","author":"Yoshitomi","year":"2019","journal-title":"Epilepsy Res"},{"issue":"8","key":"10.1016\/j.yebeh.2022.108661_b0925","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12456","article-title":"Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies","volume":"17","author":"Zhou","year":"2018","journal-title":"Genes Brain Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502200110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502200110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:46:26Z","timestamp":1761504386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550502200110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":185,"alternative-id":["S152550502200110X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108661","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical, economic, and humanistic burden of Dravet syndrome \u2013 A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108661"}}